We provide comprehensive care to more than 100 individuals newly diagnosed with myelodysplastic syndromes annually. In addition to our designation as a Center of Excellence by the Myelodysplastic Syndromes Foundation, we are recognized as a leading institution for stem cell transplantation for MDS. We direct numerous clinical trials of investigational agents and innovative treatment approaches.
E-Publications for Medical Professionals
Stay up-to-date on Memorial Sloan Kettering advances in your areas of interest.